United States · FDA National Drug Code directory
ALLI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0135-0461_4d51b8f1-a819-7ff6-e063-6294a90a82bc
- Product NDC
- 0135-0461
- Form
- CAPSULE
- Composition / generic term
- orlistat
- Labeler
- Haleon US Holdings LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070207
- Source listing expiry
- 20271231
Source-listed ingredients
- ORLISTAT — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (0135-0461-01) · 0135-0461-01
- 120 CAPSULE in 1 BOTTLE (0135-0461-05) · 0135-0461-05
- 170 CAPSULE in 1 BOTTLE (0135-0461-06) · 0135-0461-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →